[go: up one dir, main page]

ES8601869A1 - A PROCEDURE TO PREPARE VERY PURE CRYSTALLINE CEFUROXYME ESTER 1-ACETOXYETHYLENE - Google Patents

A PROCEDURE TO PREPARE VERY PURE CRYSTALLINE CEFUROXYME ESTER 1-ACETOXYETHYLENE

Info

Publication number
ES8601869A1
ES8601869A1 ES534695A ES534695A ES8601869A1 ES 8601869 A1 ES8601869 A1 ES 8601869A1 ES 534695 A ES534695 A ES 534695A ES 534695 A ES534695 A ES 534695A ES 8601869 A1 ES8601869 A1 ES 8601869A1
Authority
ES
Spain
Prior art keywords
procedure
cefuroxyme
acetoxyethylene
ester
prepare
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534695A
Other languages
Spanish (es)
Other versions
ES534695A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES8601869A1 publication Critical patent/ES8601869A1/en
Publication of ES534695A0 publication Critical patent/ES534695A0/en
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN PROCEDIMIENTO PARA OBTENER CEFUROXIMA-AXETIL CRISTALINA Y PURISIMA. COMPRENDE CRISTALIZAR CEFUROXIMA-AXETIL A PARTIR DE UNA DISOLUCION DE LA MISMA EN UN DISOLVENTE ORGANICO O ACUOSO, O EN UNA MEZCLA DE AMBOS, Y LUEGO SECAR Y AISLAR EL PRODUCTO. LOS DISOLVENTES PREFERIDOS SON ACETATOS DE ALQUILO MEZCLADOS CON ETERES O CON HIDROCARBUROS ALIFATICOS O AROMATICOS. CUANTO MAYOR SEA EL RENDIMIENTO DE LA CRISTALIZACION, EL PRODUCTO CONTENDRA UNA RELACION ESTEQUIOMETRICA DE ISOMEROS R:S MAS PROXIMA A 1:1.A PROCEDURE TO OBTAIN CEFUROXIMA-AXETIL CRISTALINA Y PURISIMA. IT INCLUDES CRYSTALIZING CEFUROXIMA-AXETIL FROM A SOLUTION OF THE SAME IN AN ORGANIC OR AQUEOUS SOLVENT, OR IN A MIXTURE OF BOTH, AND THEN DRYING AND ISOLATING THE PRODUCT. THE PREFERRED SOLVENTS ARE ALKYL ACETATES MIXED WITH ETHERS OR WITH ALIPHATIC OR AROMATIC HYDROCARBONS. THE HIGHER THE CRYSTALLIZATION YIELD, THE PRODUCT WILL CONTAIN A STECHIOMETRIC RATIO OF ISOMERS R: S CLOSER TO 1: 1.

ES534695A 1983-07-29 1984-07-27 A PROCEDURE TO PREPARE VERY PURE CRYSTALLINE CEFUROXYME ESTER 1-ACETOXYETHYLENE Granted ES534695A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838320521A GB8320521D0 (en) 1983-07-29 1983-07-29 Chemical process

Publications (2)

Publication Number Publication Date
ES8601869A1 true ES8601869A1 (en) 1985-11-01
ES534695A0 ES534695A0 (en) 1985-11-01

Family

ID=10546505

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534695A Granted ES534695A0 (en) 1983-07-29 1984-07-27 A PROCEDURE TO PREPARE VERY PURE CRYSTALLINE CEFUROXYME ESTER 1-ACETOXYETHYLENE

Country Status (21)

Country Link
JP (1) JPH0613526B2 (en)
KR (1) KR910008377B1 (en)
AT (1) AT392470B (en)
AU (2) AU582121B2 (en)
BE (1) BE900241A (en)
CA (1) CA1265511A (en)
CH (1) CH662121A5 (en)
DE (1) DE3427828A1 (en)
DK (1) DK165505C (en)
ES (1) ES534695A0 (en)
FI (1) FI76808C (en)
FR (1) FR2549837B1 (en)
GB (2) GB8320521D0 (en)
IE (1) IE57726B1 (en)
IL (1) IL72536A (en)
NL (1) NL8402372A (en)
NO (1) NO167292C (en)
NZ (1) NZ209046A (en)
PT (1) PT78985B (en)
SE (1) SE463263B (en)
ZA (1) ZA845830B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil
IT1277426B1 (en) * 1995-08-03 1997-11-10 Acs Dobfar Spa BIOAVAILABLE CRYSTALLINE FORM OF CEFUROXIMA AXETIL
CN1111537C (en) * 1997-05-15 2003-06-18 第一制糖株式会社 The preparation method of highly pure crystalline form of cefuroxime axetil
KR100228264B1 (en) * 1997-08-02 1999-11-01 김선진 The synthetic method of crystalline cefuroxime axetil
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
IN186539B (en) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
EP0937727B1 (en) * 1998-02-20 2002-01-30 Fako Ilaclari A.S. Process of preparation of soluble crystalline cefuroxime axetil
IN190849B (en) 2000-07-17 2003-08-23 Ranbaxy Lab Ltd
AT411996B (en) 2000-09-11 2004-08-26 Sandoz Ag METHOD FOR PRODUCING CEFUROXIME IN THE FORM OF ITS N-BUTYL LAMONIUM SALTS
ITMI20011763A1 (en) * 2001-08-10 2003-02-10 Antibioticos Spa HIGH-PURITY CEFUROXIME AXELITE PREPARATION PROCESS
ITMI20011925A1 (en) * 2001-09-14 2003-03-14 Antibioticos Spa METHOD APPLICABLE ON INDUSTRIAL SCALE FOR THE PREPARATION OF CEFUROXIME AXETILE CRISTALLINO
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
CN100448879C (en) * 2004-07-22 2009-01-07 北京化工大学 A kind of preparation method of amorphous cefuroxime axetil
DE102005019458A1 (en) * 2005-04-25 2006-10-26 Grünenthal GmbH Composition, useful in the preparation of pellets and the multi-particular-presentation form, comprises cefuroximaxetil and carrageenan of the group of lambda carrageenan, tau carrageenan and kappa carrageenan
CN118561870A (en) * 2024-05-15 2024-08-30 广东立国制药有限公司 Method for preparing cefuroxime acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
JPS577485A (en) * 1980-06-13 1982-01-14 Takeda Chem Ind Ltd Cephalosporin
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics

Also Published As

Publication number Publication date
ATA244484A (en) 1990-09-15
FI76808B (en) 1988-08-31
CH662121A5 (en) 1987-09-15
FI843011L (en) 1985-01-30
GB2145409B (en) 1987-02-18
FI76808C (en) 1988-12-12
DK366684D0 (en) 1984-07-27
KR850001221A (en) 1985-03-16
FI843011A0 (en) 1984-07-27
NO167292C (en) 1991-10-23
JPS6075484A (en) 1985-04-27
FR2549837A1 (en) 1985-02-01
NZ209046A (en) 1988-02-29
FR2549837B1 (en) 1986-12-26
BE900241A (en) 1985-01-28
AU634965B2 (en) 1993-03-11
JPH0613526B2 (en) 1994-02-23
GB2145409A (en) 1985-03-27
DK165505B (en) 1992-12-07
IL72536A0 (en) 1984-11-30
KR910008377B1 (en) 1991-10-12
SE8403897D0 (en) 1984-07-27
AU3125684A (en) 1985-01-31
DK165505C (en) 1993-04-19
PT78985A (en) 1984-08-01
NO167292B (en) 1991-07-15
NO843055L (en) 1985-01-30
IL72536A (en) 1988-01-31
IE57726B1 (en) 1993-03-24
GB8419202D0 (en) 1984-08-30
PT78985B (en) 1986-10-23
AU582121B2 (en) 1989-03-16
AU3660189A (en) 1989-10-05
IE841938L (en) 1985-01-29
NL8402372A (en) 1985-02-18
ZA845830B (en) 1986-03-26
CA1265511A (en) 1990-02-06
SE463263B (en) 1990-10-29
DE3427828A1 (en) 1985-02-14
DK366684A (en) 1985-01-30
AT392470B (en) 1991-04-10
SE8403897L (en) 1985-01-30
GB8320521D0 (en) 1983-09-01
ES534695A0 (en) 1985-11-01

Similar Documents

Publication Publication Date Title
ES8601869A1 (en) A PROCEDURE TO PREPARE VERY PURE CRYSTALLINE CEFUROXYME ESTER 1-ACETOXYETHYLENE
AU512448B2 (en) The use of cyclic carbonic acid esters as solvents for poly-(b-hydroxy butric acid
BE854197A (en) NEW MALONIC ACID ESTERS USED FOR THE STABILIZATION OF ORGANIC MATTERS
ES2070536T3 (en) SALICILOIL-CARNITINE AND PROCEDURE FOR ITS PREPARATION.
ES2051731T3 (en) A PROCEDURE FOR PREPARING MACROLID ANTIBIOTICS AND THEIR USE.
JPS52250A (en) Process for preparation of 8-exo-hydroxy-endo-tricyclo-(5,2,2,02,6) ) unde cane
JPS52109545A (en) Preparation of aqueous polyolefin dispersions
ES8400089A1 (en) PROCEDURE FOR PREPARING DERIVATIVES OF FENANTRENO.
JPS5287157A (en) Preparation of provitamin d compounds
JPS5441664A (en) Polishing method for indium phosphorus crystal
JPS5283750A (en) Crystals of 5-amino-4-imidazol-carboxyamide
JPS5268116A (en) Preparation of alkoxyalkylidene compounds
JPS51143606A (en) Process for preparation of 1,3- propanediols
JPS5326823A (en) Preparation of 6,13-dihydroquinacridone
JPS52151148A (en) Preparation of substituted cyclopropanecarboxylic acid derivatives
JPS5280384A (en) Preparation of graft polymers
JPS5318549A (en) Preparation of optical active compounds by irradiation
JPS51136643A (en) Process for preparation of aromatic ester derivatives
JPS5211169A (en) Pure water producing apparatus
JPS5289684A (en) Preparation of triesters of isocyanuric acid
ES2081520T3 (en) PROCEDURE FOR DEPURATION OF DIAMINODIFENIL COMPOUNDS.
JPS5268229A (en) Preparation of bisoxazolyl ethylene compound
JPS5265257A (en) Synthesis of tricyclo 6,2,1,0 undecane
JPS5287156A (en) Isolation of provitamin d compounds
JPS5214758A (en) Preparation of carboxyl-containing derivatives